ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 036,24
0,54%
Dow Jones
38 686,32
0,00%
DAX
18 676,54
1,05%
Brent Oil
80,715
-0,11%
Bitcoin
69 589,09
2,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Otonomy Inc (OTIC)

  7. Otonomy Inc (OTIC) Actualités

OTIC

Otonomy (OTIC)

Otonomy Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OTIC
DateHeureSourceTitreSymboleSociété
04/04/202321h41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OTICOtonomy Inc
03/04/202312h19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OTICOtonomy Inc
30/03/202322h32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OTICOtonomy Inc
30/03/202322h26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OTICOtonomy Inc
30/03/202322h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
24/02/202322h56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTICOtonomy Inc
14/02/202322h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
13/02/202322h57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OTICOtonomy Inc
30/01/202312h38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OTICOtonomy Inc
30/12/202222h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
29/12/202215h37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTICOtonomy Inc
27/12/202223h11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OTICOtonomy Inc
22/12/202213h53GlobeNewswire Inc.Otonomy Announces Change in Stock Exchange ListingNASDAQ:OTICOtonomy Inc
19/12/202223h29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OTICOtonomy Inc
19/12/202222h53GlobeNewswire Inc.Otonomy Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
10/11/202222h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
10/11/202222h05GlobeNewswire Inc.Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
13/10/202213h30GlobeNewswire Inc.Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
02/08/202222h26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/08/202212h16TipRanksAnalyst Explains Why They Downgraded Their Rating on Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
01/08/202213h30GlobeNewswire Inc.Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusNASDAQ:OTICOtonomy Inc
25/07/202222h05GlobeNewswire Inc.Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
18/07/202213h30GlobeNewswire Inc.Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
18/05/202213h30GlobeNewswire Inc.Otonomy to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:OTICOtonomy Inc
12/05/202213h30GlobeNewswire Inc.Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual MeetingNASDAQ:OTICOtonomy Inc
09/05/202222h04GlobeNewswire Inc.Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
02/05/202213h30GlobeNewswire Inc.Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
25/04/202212h15TipRanksAnalysts Offer Insights on Healthcare Companies: Amryt Pharma (AMYT) and Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
20/04/202213h30GlobeNewswire Inc.Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
15/03/202212h30GlobeNewswire Inc.Otonomy to Host Virtual Investor R&D Event on March 22, 2022NASDAQ:OTICOtonomy Inc
 Showing the most relevant articles for your search:NASDAQ:OTIC

Dernières Valeurs Consultées

BOV
CORR4
COR RIBEIRO PN
LSE
CMCG
Ivz Bbg Cmod Ct
BIT
Q00011
Leonteq Securities
BOV
BBDCF168
BBDCF168 Ex:16,17
BIT
S28226
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés